İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

57.4 F
San Diego
Monday, May 20, 2024
-Advertisement-

Otonomy’s Ear Treatments Catch Eye of Investors to Tune of $49 Million in Series D Round

Otonomy Inc. has raised $49 million in a Series D round to further advance its treatments for diseases of the ear.

The company has raised nearly $145 million since its launch six years ago, including a Series C round in September for $45.9 million.

The company has two drug candidates in clinical development that are advancing to late-stage trial: a steroid that treats vertigo in patients with Meniere’s disease and an antibiotic for children undergoing ear tube placement surgery.

The newest investors in the oversubscribed round include Jennison Associates LLC, Perceptive Advisors and Federated Kaufmann Funds. All Otonomy’s previous investors also participated in this most recent financing round.

To read more on this story, see the May 5 edition of the San Diego Business Journal.

-Advertisement-

Featured Articles

Hair Today, Hair Tomorrow

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-